Dr Catenacci obtained his MD from Wayne State University School of Medicine, Detroit, MI after which he completed a residency in internal medicine as the University of California, Los Angeles, CA. He subsequently went on to earn an MSc in Health Studies from the University of Chicago, Chicago, IL. Following this, Dr Catenacci held positions at the The University of Chicago Pritzker School of Medicine and University of Chicago Comprehensive Cancer Center and was an Associate Professor of Medicine at University of Chicago Medicine.
Speaking on personalized treatment, IO, and precision medicine for gastroesophageal and other GI cancers
In addition to his clinical work Dr Catenacci is an active researcher, with over 250 publications in renowned, peer-reviewed journals. His research focuses on bench-to-bedside translational research for the treatment of gastroesophageal and other gastrointestinal cancers, with the aim of validating and improving personalized treatment, immunotherapy, and precision medicine. Specifically, Dr Catenacci’s research has focused on the quantification of genetic molecular tumor heterogeneity, both within and between individuals, and the impact of this on personalized therapeutic approaches.